TDF showed a trend of unfavorable renal safety even in short term treatment, although there was no statistical difference in 4-week changes of renal function among three groups.
← all excerpts
Short-term and long-term safety and efficacy of tenofovir alafenamide, tenofovir disoproxil fumarate and entecavir treatment of acute-on-chronic liver failure associated with hepatitis B.
1
—
—